Aurobindo Pharma Ltd. (AUROPHARMA)
BSE
Closed
Oct 9, 2026
Day's Range
1,633.3552 wk Range
1,075.05Overview - AUROPHARMA - Aurobindo Pharma Ltd.
Key Statistics
Valuation
Enterprise Value
675.66B
P/E (Trailing)
‪27.88‬
P/E (Forward)
‪21.91‬
PEG Ratio
‪21.91‬
Price / Sales (TTM)
‪2.93‬
Price / Book
‪2.72‬
EV / EBITDA
‪10.27‬
Profitability
Gross Margin
‪60.16%‬
Profit Margin
‪10.52%‬
Operating Margin
‪15.07%‬
Return on Assets
‪6.30%‬
Return on Equity
‪10.37%‬
Ownership
Shares Outstanding
580.80M
Float
267.84M
Held by Insiders
‪54.19%‬
Held by Institutions
‪29.88%‬
Price stats
Beta
‪0.05‬
50-Day Avg
‪1,191.50‬
200-Day Avg
‪1,147.20‬
Dividends
Payout Ratio
‪6.79%‬
Frequency
Semi-Annual
Analyst Consensus
28 analysts
Average price target
‪₹ 1,318.62‬Market Cap - AUROPHARMA - Aurobindo Pharma Ltd.
Peers - AUROPHARMA - Aurobindo Pharma Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on BSE.
- AUROPHARMABSEAurobindo Pharma Ltd.980.78BMarket Cap+32.58%52-week change27.88P/E (Trailing)‪10.52%‬Profit Margin
- DIVISLABBSEDivi's Laboratories Ltd.2.47TMarket Cap+29.72%52-week change84.62P/E (Trailing)‪26.04%‬Profit Margin
- LAURUSLABSBSELaurus Labs Ltd.1.07TMarket Cap+56.59%52-week change98.03P/E (Trailing)‪15.04%‬Profit Margin
- CIPLABSECipla Ltd.1.05TMarket Cap-20.00%52-week change23.19P/E (Trailing)‪16.25%‬Profit Margin
- DRREDDYBSEDr. Reddy's Laboratories Ltd.1.00TMarket Cap-2.69%52-week change17.73P/E (Trailing)‪16.36%‬Profit Margin
- MANKINDBSEMankind Pharma Ltd.978.50BMarket Cap-3.07%52-week change47.92P/E (Trailing)‪13.85%‬Profit Margin
- LUPINBSELupin Ltd.895.65BMarket Cap-0.53%52-week change20.77P/E (Trailing)‪17.47%‬Profit Margin
Profile Summary - AUROPHARMA - Aurobindo Pharma Ltd.
About
Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in manufacturing and marketing a vast array of medicinal products across global markets. Established in 1986 and headquartered in Hyderabad, India, the company focuses on developing generic pharmaceutical formulations and active pharmaceutical…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
